[MeMed in AACC] Diagnosis on Day Zero
The winner of AACC’s 2021 Disruptive Technology Award married machine learning and genomics to rapidly identify bloodstream infections. Read more...
Read MoreDec 1, 2021 | News Center
The winner of AACC’s 2021 Disruptive Technology Award married machine learning and genomics to rapidly identify bloodstream infections. Read more...
Read MoreJul 27, 2021 | News Center
MeMed, a host response-based technologies specialist, has received the CE Mark in Europe for its new disease management solution, MeMed COVID-19 Severity. Read more...
Read MoreJun 18, 2021 | News Center
Bronstein, Zilberberg, Chueiri & Potenza Advogados represented Memed in the transaction. Memed, national leader in digital medical prescriptions, has agreed a contribution of 300 million reais through a fund structured by DNA Capital. Read more...
Read MoreFeb 11, 2021 | News Center, Newsticker
In honor of the International Day of Women and Girls in Science, MeMed’s Dr. Mary Hainrichson offers some words of encouragement. Read more...
Read MoreOct 25, 2020 | News Center, Newsticker
Growing biopharmaceutical company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers. Read more...
Read More